Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Masako, Toyosaki"'
Autor:
Hidetsugu Kawai, Sawako Shiraiwa, Daisuke Ogiya, Masako Toyosaki, Shinichiro Machida, Rikio Suzuki, Makoto Onizuka, Yoshiaki Ogawa, Hiroshi Kawada
Publikováno v:
Leukemia Research Reports, Vol 22, Iss , Pp 100478- (2024)
The t(10;17)(p15;q21) translocation is a very rare recurrent cytogenetic aberration, and produced ZMYND11::MBTD1 fusion gene. To date, nine cases of acute leukemia with the t(10;17)(p15;q21) translocation have been reported, but the case of AML with
Externí odkaz:
https://doaj.org/article/898cfaa47ad54b6f9b8a5ac5d1b811b3
Autor:
Makoto Onizuka, Tadashi Imanishi, Kaito Harada, Yasuyuki Aoyama, Jun Amaki, Masako Toyosaki, Shinichiro Machida, Eri Kikkawa, Sanetoshi Yamada, Kazuhiko Nakabayashi, Kenichiro Hata, Ken Higashimoto, Hidenobu Soejima, Kiyoshi Ando
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-6 (2023)
Abstract Cord blood stem cell transplantation is an important alternative for patients needing hematopoietic stem cell transplantation. However, it is unclear how cord blood cells, which are 0 years old, age in the recipient’s body after allogeneic
Externí odkaz:
https://doaj.org/article/314c33dbb52f48e191278cd7a0bc3331
Autor:
Kaito Harada, Mari Morita-Fujita, Takahiro Fukuda, Yukiyasu Ozawa, Noriko Doki, Masako Toyosaki, Yumiko Maruyama, Yoshinobu Kanda, Takashi Ashida, Tetsuya Eto, Satoru Takada, Naoyuki Uchida, Tatsuo Ichinohe, Junya Kanda, Makoto Onizuka, Yoshiko Atsuta, Shinichi Kako, Yasuyuki Arai
Publikováno v:
Cytotherapy. 24(9):954-961
BACKGROUND AIMS: An intensified conditioning regimen incorporating medium-dose etoposide (VP16) is an option for patients with acute lymphoblastic leukemia (ALL). However, the prognostic impacts of the addition of VP16 to cyclophosphamide (CY) and to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4a2a83ed39a08b98ae07817b41d606a
http://hdl.handle.net/2433/279365
http://hdl.handle.net/2433/279365
Autor:
Makoto Onizuka, Hiromichi Matsushita, Ryujiro Hara, Sawako Shiraiwa, Ken Ohmachi, Daisuke Ogiya, Masako Toyosaki, Yoshiaki Ogawa, Hiroshi Kawada, Yasuyuki Aoyama, Eri Kikkawa, Kaito Harada, Rikio Suzuki, Kiyoshi Ando, Sinichiro Machida
Publikováno v:
Annals of Hematology. 100:2479-2486
The prognosis of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) has improved dramatically. Although measurable residual disease (MRD) kinetics during pretransplant treatment has been recently reported to correlate with patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d32c8d7a3901a8dca17b39f93e4bb83
https://doi.org/10.1007/s00277-021-04587-9
https://doi.org/10.1007/s00277-021-04587-9
Autor:
Ryujiro Hara, Toshihiko Kitahara, Hiroki Numata, Masako Toyosaki, Shigeki Watanabe, Eri Kikkawa, Yoshiaki Ogawa, Hiroshi Kawada, Kiyoshi Ando
Publikováno v:
International journal of hematology.
The relationship between fetal hemoglobin (HbF) levels and disease prognosis in patients with myelodysplastic syndrome (MDS) is unclear. This study aimed to clarify the relationship between HbF level and the prognosis of MDS. To this end, data from 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dcbaaea4918774c3cc362a5905006e5
https://pubmed.ncbi.nlm.nih.gov/36574168
https://pubmed.ncbi.nlm.nih.gov/36574168
Autor:
Makoto Onizuka, Yoshiaki Ogawa, Ken Ohmachi, Yara Yukie Kikuti, Naoya Nakamura, Ryujiro Hara, Daisuke Ogiya, Masayuki Iwazaki, Kaito Harada, Eri Kikkawa, Masako Toyosaki, Sinichiro Machida, Hiroshi Kawada, Yasuyuki Aoyama, Kiyoshi Ando, Rikio Suzuki, Ryota Masuda
Publikováno v:
International Journal of Hematology. 113:606-610
The Janus kinase/signal transducers and activators of transcription signaling pathway induces programmed death ligand-1 (PD-L1) expression. JAK2 mutation at position 617 (JAK2V617) is a frequent driver of myeloproliferative neoplasms (MPN) through PD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c58720abe8eca9842e5525a622b2ffa6
https://doi.org/10.1007/s12185-020-03046-x
https://doi.org/10.1007/s12185-020-03046-x
Autor:
Kaito Harada, Yuho Najima, Motohiro Kato, Shigeo Fuji, Akihito Shinohara, Hirohisa Nakamae, Masako Toyosaki, Miho Ashiarai, Makoto Onizuka, Yoshiko Hashii, Tatsuo Ichinohe, Yoshiko Atsuta, Hideki Nakasone
Publikováno v:
International journal of hematology. 116(5)
Haploidentical donors have emerged as an alternative donor source for salvage stem cell transplantation (SCT) after graft failure; however, data regarding salvage haploidentical SCT using posttransplant cyclophosphamide (PTCy) are limited. Using nati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3aac32b8f98b1855b06f9683a7cc6f4
https://pubmed.ncbi.nlm.nih.gov/35767142
https://pubmed.ncbi.nlm.nih.gov/35767142
Autor:
Sawako Shiraiwa, Kaito Harada, Makoto Onizuka, Shohei Kawakami, Ryujiro Hara, Yasuyuki Aoyama, Jun Amaki, Daisuke Ogiya, Rikio Suzuki, Masako Toyosaki, Shinichiro Machida, Ken Omachi, Hiroshi Kawada, Yoshiaki Ogawa, Kiyoshi Ando
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 28(9)
Influenza virus infection (IVI) is frequent in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients, and reports from several countries indicate high morbidity and mortality from progression to lower respiratory tract disease (LR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13c5e472cce316981491cfd3a2b44953
https://pubmed.ncbi.nlm.nih.gov/35691863
https://pubmed.ncbi.nlm.nih.gov/35691863
Autor:
Heiwa Kanamori, Maki Hagihara, Hideki Nakasone, Aiko Igarashi, Masako Toyosaki, Makoto Onizuka, Rika Sakai, Noriko Doki, Ayumi Numata, Reiko Watanabe, Takeshi Kobayashi, Jun Kato, Takayoshi Tachibana, Takeshi Saito, Yuya Koda, Seiko Kato, Yoshinobu Kanda, Chikako Ohwada, Yuki Nakajima, Satoshi Koyama, Shin Fujisawa, Chiaki Nakaseko, Yasuyuki Aoyama, Masatsugu Tanaka, Emiko Sakaida, Katsuhiro Shono, Hiroaki Shimizu, Shinichiro Okamoto, Takehiko Mori
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:162-170
To prospectively validate the incidence, manifestations, and outcomes of graft-versus-host disease (GVHD) by National Institutes of Health criteria, we recruited 406 hematopoietic stem cell transplantation recipients at 16 transplant centers in Japan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f5a315ed04faebf2b96388df8e73c47
https://doi.org/10.1016/j.bbmt.2019.09.016
https://doi.org/10.1016/j.bbmt.2019.09.016
Autor:
Nozomi Yoshinari, Toshiro Kawakita, Masako Toyosaki, Souichi Shiratori, Susumu Nakahara, Noriko Doki, Tomoo Osumi, Masaya Okada, Yasunori Ueda, Masashi Sawa, Takayuki Ishikawa
Publikováno v:
Transplantation and cellular therapy. 27(10)
Chronic graft-versus-host disease (cGVHD) is a serious complication after allogeneic stem cell transplantation. There are no well-established treatment options for cGVHD after primary steroid-based treatment. Ibrutinib showed clinical benefit with an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9840bfcbd634362159fc297911143889
https://pubmed.ncbi.nlm.nih.gov/34102349
https://pubmed.ncbi.nlm.nih.gov/34102349